← Back
Data updated: Mar 10, 2026
GATE PHARMS
Infectious DiseaseDermatology
GATE PHARMS is a generic drug manufacturer focused on Infectious Disease, Dermatology.
2016
Since
1
Drugs
-
Trials
41
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
LINEZOLID 2025-12-08
LINEZOLID 2025-07-03
Labeling
LINEZOLID 2025-05-23
Labeling
LINEZOLID 2025-05-23
Labeling
LINEZOLID 2025-05-23
Labeling
LINEZOLID 2025-05-23
Labeling
LINEZOLID 2025-05-22
Labeling
LINEZOLID 2025-05-22
Labeling
LINEZOLID 2025-05-22
Labeling
LINEZOLID 2025-05-08
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 50%
1 drugs
Dermatology 50%
1 drugs
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2016-02-05
- Latest
- 2016-02-05
- Applications
- 1